1. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial. Issue 7 (July 2015) Authors: Fizazi, Karim; Faivre, Laura; Lesaunier, François; Delva, Remy; Gravis, Gwenaëlle; Rolland, Frédéric; Priou, Frank; Ferrero, Jean-Marc; Houede, Nadine; Mourey, Loïc; Theodore, Christine; Krakowski, Ivan; Berdah, Jean-François; Baciuchka, Marjorie; Laguerre, Brigitte; Fléchon, Aude; Ravaud, Alain;... Journal: Lancet oncology Issue: Volume 16:Issue 7(2015:Jul.) Page Start: 787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational study. (June 2014) Authors: Lebret, Thierry; Culine, Stéphane; Davin, Jean-Louis; Hennequin, Christophe; Mignard, Jean-Pierre; Moreau, Jean-Luc; Rossi, Dominique; Zerbib, Marc; Mahmoudi, Abdel; Latorzeff, Igor Journal: Aging male Issue: Volume 17:Number 2(2014:Jun.) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: a French prospective observational study. (December 2014) Authors: Lebret, Thierry; Davin, Jean-Louis; Hennequin, Christophe; Latorzeff, Igor; Mignard, Jean-Pierre; Moreau, Jean-Luc; Rossi, Dominique; Ruffion, Alain; Zerbib, Marc; Culine, Stéphane Journal: Therapeutic advances in urology Issue: Volume 6:Number 6(2014:Dec.) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗